Company Information

  

Address: 501 CANAL BLVD
POINT RICHMOND TECH CNTR. 
City: RICHMOND 
State: CA 
Zip Code: 94804 
Telephone: 510-970-6000 

Description of Business

Primary SIC Code: 2836
(As filed with the SEC)  

We are a clinical stage biotechnology company focused on translating ground-breaking science into genomic therapies that transform patients' lives using our industry-leading platform technologies in genome editing, gene therapy, gene regulation and cell therapy. Our proprietary zinc finger DNA-binding proteins (ZFP) technology enables efficient and highly specific genome editing and gene regulation, and we are developing genome editing and gene therapies for the treatment of genetically tractable diseases. We have several proprietary clinical and preclinical programs in development and have strategically partnered certain programs with biopharmaceutical companies to obtain funding for our own programs and to expedite clinical and commercial development. Our long-term goal is to forward integrate into manufacturing, development and commercial operations to more fully capture the value of our proprietary genome editing and gene therapy products.  ... More ...  

Per Share Overview

Date 12-mos Rolling EPS Dividend P/E Ratio
09/2017-0.69NAN/E
06/2017-0.82NAN/E
03/2017-1.02NAN/E
12/2016-1.02NAN/E
09/2016-1.08NAN/E
06/2016-0.94NAN/E
03/2016-0.73NAN/E
12/2015-0.58NAN/E

Key Financial Ratios and Statistics

FYE: 12/31

Profitability 2016 Leverage 2016
Net Inc/Comm Equity-0.12Total Liab/Total Assets0.14
Net Inc/Total Assets-0.45Total Liab/Inv Cap0.15
Net Inc/Inv Cap-0.50Total Liab/Comm Equity0.04
Pretax Inc/Net Sales-3.70Interest Coverage RatioNA
Net Inc/Net Sales-3.70Curr Debt/EquityNA
Cash Flow/Net Sales-3.40LTD/Equity0.03
SG&A/NetSales1.36Total Debt/Equity0.03
Asset Utilization   Liquidity  
Net Receivables Turnover4.83Quick Ratio11.25
Inventory TurnoverNACurrent Ratio11.25
Inventory Day SalesNANet Rec/Curr Assets0.03
Net Sales/Work Cap0.14Inv/Curr AssetsNA
Net Sales/PP&E2.96  

Income Statement (Millions)

  9/30/2017 6/30/2017 3/31/2017 12/31/2016
Total Revenues(Net Sales) 11.81 8.25 3.43 8.92
Cost of Goods Sold NA NA NA NA
Selling & Admin Exps 6.42 6.04 7.28 4.86
Operating Income -13.04 -12.77 -16.79 -9.83
Interest Exp NA NA NA NA
Pretax Income -12.35 -12.49 -16.63 -9.61
Other Income 0.68 0.28 0.16 0.22
Net Income Bef Extraordinary ... NA NA NA NA
Net Income -12.35 -12.49 -16.63 -9.62

Balance Sheet (Millions)

Assets 9/30/2017 6/30/2017 3/31/2017 12/31/2016
Cash & Short Term Investments 236.70 249.91 129.27 142.54
Receivables - Total 3.92 3.75 2.80 5.20
Inventories - Total NA NA NA NA
Total Current Assets 242.34 255.68 133.77 149.58
Net Property, Plant & Equipment 8.50 8.35 7.27 6.56
Total Assets 269.79 282.99 146.81 157.89
Liabilities        
Accounts Payable 14.59 12.12 9.46 9.15
Debt in Current Liabilities NA NA NA NA
Total Current Liabilities 42.94 41.66 13.06 13.29
Long-Term Debt 3.87 3.89 3.93 3.95
Total Liabilities 83.14 88.95 21.13 21.70
Stockholder's Equity        
Minority Interest NA NA NA NA
Preferred Stock NA NA NA NA
Common Stock 0.84 0.84 0.72 0.71
Retained Earnings -482.39 -470.03 -457.54 -440.91
Treasury Stock NA NA NA NA
Total Stockholders' Equity 186.65 194.04 125.68 136.20
Total Liabilities and Stockholders' Equity 269.79 282.99 146.81 157.89

Cash Flow Summary (Millions)

Categories 9/30/2017 6/30/2017 3/31/2017 12/31/2016
Net Cash Provided by Operating Activities -15.69 56.79 -13.08 -11.77
Net Cash Provided by Investing Activities -27.06 -84.37 6.06 6.27
Net Cash Provided by Financing Activities 2.81 78.94 3.44 -0.42

Annual Summary Data (Millions)

Year Sales Net Income EPS
12/201221.66-22.26-0.42
12/201324.13-26.62-0.48
12/201445.87-26.42-0.39
12/201539.54-40.70-0.58
12/201619.39-71.66-1.02
Growth Rates-2.73----

Stock Ownership

Type Date(Q,M) No. Owners Shares Held (000s) % Own
Institutional09/30/1717254,39664.36




Report Date : 12/11/2017

Powered By Edgar Online © 2017EDGAR®Online, a division of Donnelley Financial Solutions. EDGAR® is a federally registered trademark of the U.S. Securities and Exchange Commission. EDGAR Online is not affiliated with or approved by the U.S. Securities and Exchange Commission.